Herpes type-2 viruses and gynaecological malignancies.
Numerous sero-epidemiologic studies have noted an association between Herpes Type 2 (HT-2) virus and carcinoma of the cervix. In a study to evaluate the role of this virus, if any, on the etiology of extra cervical pelvic malignancies in Ibadan, the prevalence of HT-2 virus antibodies was found not to be significantly different in patients with extra cervical pelvic malignancies (carcinoma of the vulva and malignant trophoblastic disease) and cases of chronic cervicitis when compared with healthy controls. It was therefore concluded that no association could be found between HT-2 virus and extra cervical pelvic malignancies.
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D002277:Carcinoma / Q000209:etiology; D005260:Female; D005833:Genital Neoplasms, Female / Q000209:etiology*; D006566:Herpesviridae Infections / Q000150:complications*; D006801:Humans; D011247:Pregnancy; D018139:Simplexvirus / Q000276:immunology*; D014328:Trophoblastic Neoplasms / Q000209:etiology; D002583:Uterine Cervical Neoplasms / Q000209:etiology; D014846:Vulvar Neoplasms / Q000209:etiology
D000914:Antibodies, Viral